Nucleus-specific alteration of raphe neurons in human neurodegenerative disorders

Neurodegenerative diseases share symptoms suggested to be related to the serotonergic system. To evaluate the involvement of serotonergic raphe nuclei, we compared the percentage of neurons synthesizing serotonin in the nucleus centralis superior (NCS), raphe obscurus and pallidus (NROP) in Alzheime...

Full description

Saved in:
Bibliographic Details
Published inNeuroreport Vol. 14; no. 1; p. 73
Main Authors Kovacs, Gabor G, Klöppel, Stefan, Fischer, Ingeborg, Dorner, Suzanne, Lindeck-Pozza, Elisabeth, Birner, Peter, Bötefür, Ingolf C, Pilz, Peter, Volk, Benedikt, Budka, Herbert
Format Journal Article
LanguageEnglish
Published England 20.01.2003
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Neurodegenerative diseases share symptoms suggested to be related to the serotonergic system. To evaluate the involvement of serotonergic raphe nuclei, we compared the percentage of neurons synthesizing serotonin in the nucleus centralis superior (NCS), raphe obscurus and pallidus (NROP) in Alzheimer's disease (AD), progressive supranuclear palsy (PSP), Parkinson's disease (PD), multiple system atrophy (MSA), and control brains. We used immunohistochemistry for tryptophan hydroxylase (TpOH), phosphorylated tau, and alpha-synuclein. We observed a significant decrease in the NCS in the NROP in AD, but a significant increase in PSP and MSA. Cytoskeletal pathology was present in the NCS and NROP to a variable degree. We conclude that there is disease- and nucleus-specific alteration of serotonin synthesis in the raphe.
AbstractList Neurodegenerative diseases share symptoms suggested to be related to the serotonergic system. To evaluate the involvement of serotonergic raphe nuclei, we compared the percentage of neurons synthesizing serotonin in the nucleus centralis superior (NCS), raphe obscurus and pallidus (NROP) in Alzheimer's disease (AD), progressive supranuclear palsy (PSP), Parkinson's disease (PD), multiple system atrophy (MSA), and control brains. We used immunohistochemistry for tryptophan hydroxylase (TpOH), phosphorylated tau, and alpha-synuclein. We observed a significant decrease in the NCS in the NROP in AD, but a significant increase in PSP and MSA. Cytoskeletal pathology was present in the NCS and NROP to a variable degree. We conclude that there is disease- and nucleus-specific alteration of serotonin synthesis in the raphe.
Author Klöppel, Stefan
Lindeck-Pozza, Elisabeth
Bötefür, Ingolf C
Kovacs, Gabor G
Pilz, Peter
Volk, Benedikt
Budka, Herbert
Birner, Peter
Fischer, Ingeborg
Dorner, Suzanne
Author_xml – sequence: 1
  givenname: Gabor G
  surname: Kovacs
  fullname: Kovacs, Gabor G
  organization: Institute of Neurology, University of Vienna, Austria
– sequence: 2
  givenname: Stefan
  surname: Klöppel
  fullname: Klöppel, Stefan
– sequence: 3
  givenname: Ingeborg
  surname: Fischer
  fullname: Fischer, Ingeborg
– sequence: 4
  givenname: Suzanne
  surname: Dorner
  fullname: Dorner, Suzanne
– sequence: 5
  givenname: Elisabeth
  surname: Lindeck-Pozza
  fullname: Lindeck-Pozza, Elisabeth
– sequence: 6
  givenname: Peter
  surname: Birner
  fullname: Birner, Peter
– sequence: 7
  givenname: Ingolf C
  surname: Bötefür
  fullname: Bötefür, Ingolf C
– sequence: 8
  givenname: Peter
  surname: Pilz
  fullname: Pilz, Peter
– sequence: 9
  givenname: Benedikt
  surname: Volk
  fullname: Volk, Benedikt
– sequence: 10
  givenname: Herbert
  surname: Budka
  fullname: Budka, Herbert
BackLink https://www.ncbi.nlm.nih.gov/pubmed/12544834$$D View this record in MEDLINE/PubMed
BookMark eNo1j9tKAzEYhHNRsQd9BckLRP8cNtlcSvFQKIqg1yWb_LEru9kl6Qq-vdXqXMzAxzAwSzJLQ0JCKIdrDtbcwFHcVJoJAAn86OyHqBlZgK0sU1ZXc7Is5eOILfD6nMy5qJSqpVqQl6fJdzgVVkb0bWw9dd0Bszu0Q6JDpNmNe6QJpzykQttE91Pv0gkEfMf02_1EGtoy5IC5XJCz6LqCl3-5Im_3d6_rR7Z9ftisb7fMK24Uk9FXWAuUPApfN6bBJkgThARbx9hw7rX3FjQ00njwQVceUCsXIEQRwIkVuTrtjlPTY9iNue1d_tr9fxPfoztUUw
CitedBy_id crossref_primary_10_1002_ana_20021
crossref_primary_10_1016_j_brainres_2005_08_004
crossref_primary_10_1016_j_pneurobio_2016_07_002
crossref_primary_10_1007_s11055_014_9983_5
crossref_primary_10_1007_s12264_017_0170_x
crossref_primary_10_1016_j_neuropharm_2011_01_006
crossref_primary_10_1016_j_expneurol_2013_06_015
crossref_primary_10_1016_j_brainres_2008_12_034
crossref_primary_10_1016_j_brainres_2023_148423
crossref_primary_10_3390_ijms26031234
crossref_primary_10_1007_s10072_011_0595_3
crossref_primary_10_1002_mds_22533
crossref_primary_10_1016_j_pneurobio_2020_101900
crossref_primary_10_1016_j_resp_2011_06_030
crossref_primary_10_1016_j_brainres_2005_11_056
crossref_primary_10_1016_j_nbd_2011_10_026
crossref_primary_10_1002_jnr_23054
crossref_primary_10_1016_j_nbd_2015_10_021
crossref_primary_10_1007_s00702_021_02347_7
crossref_primary_10_3390_biomedicines11020541
crossref_primary_10_1016_j_mehy_2005_07_033
crossref_primary_10_1007_s00415_010_5666_5
crossref_primary_10_1002_cne_21985
crossref_primary_10_1016_j_jchemneu_2010_12_003
crossref_primary_10_1111_j_1460_9568_2012_08200_x
crossref_primary_10_1517_14728210802596906
crossref_primary_10_1007_s11882_018_0796_4
crossref_primary_10_31083_j_jin2004108
crossref_primary_10_1016_j_neurobiolaging_2018_12_006
crossref_primary_10_1016_j_neucli_2009_07_001
crossref_primary_10_1016_j_neuroscience_2008_12_051
crossref_primary_10_3390_molecules27175456
crossref_primary_10_1016_j_neuropharm_2023_109645
crossref_primary_10_3233_JAD_161118
crossref_primary_10_1111_jnc_13253
crossref_primary_10_3233_JAD_160623
crossref_primary_10_1126_sciadv_adl2675
crossref_primary_10_1016_j_jchemneu_2018_12_011
crossref_primary_10_1186_s13024_021_00456_1
crossref_primary_10_1007_s12035_011_8230_0
crossref_primary_10_1111_j_1365_2990_2009_01038_x
crossref_primary_10_18679_CN11_6030_R_2016_019
crossref_primary_10_1038_nrneurol_2012_80
crossref_primary_10_1111_j_1471_4159_2010_07123_x
crossref_primary_10_1007_s13273_012_0034_4
crossref_primary_10_1002_cne_20994
crossref_primary_10_3233_JAD_180005
crossref_primary_10_1016_j_pneurobio_2012_06_010
crossref_primary_10_1155_2012_323686
crossref_primary_10_3390_ijms22084286
ContentType Journal Article
Copyright Copyright 2003 Lippincott Williams & Wilkins
Copyright_xml – notice: Copyright 2003 Lippincott Williams & Wilkins
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1097/00001756-200301200-00014
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 12544834
Genre Journal Article
GroupedDBID ---
-~X
.-D
.GJ
.Z2
0R~
123
4Q1
5RE
5VS
AAAAV
AAHPQ
AAIQE
AAMTA
AARTV
AAYEP
ABBUW
ABDIG
ABJNI
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACWDW
ACWRI
ACXNZ
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEETU
AENEX
AFDTB
AGINI
AHQNM
AHVBC
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
ALKUP
ALMA_UNASSIGNED_HOLDINGS
AMJPA
AMNEI
AWKKM
BQLVK
BS7
BYPQX
C45
CGR
CS3
CUY
CVF
DIWNM
DU5
DUNZO
E.X
EBS
ECM
EIF
EJD
EX3
F2K
F2L
F5P
FCALG
FL-
H0~
HZ~
IKREB
IN~
JK3
JK8
K8S
KD2
KMI
L-C
N9A
NPM
N~M
O9-
OAG
OCUKA
ODA
OL1
OLG
OLV
OLW
OLZ
OPUJH
OPX
ORVUJ
OUVQU
OVD
OVDNE
OWV
OWZ
OXXIT
P2P
R58
RLZ
S4R
S4S
TEORI
V2I
W3M
WOQ
WOW
X3V
X3W
XYM
YFH
ZFV
ZGI
ZXP
ZZMQN
ID FETCH-LOGICAL-c4174-3fc5e82e31f2c8b7bebd37d23098ffb11c6cc9060b37c0cd65c0e64ad0df2d0a2
ISSN 0959-4965
IngestDate Wed Feb 19 02:33:37 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Copyright 2003 Lippincott Williams & Wilkins
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4174-3fc5e82e31f2c8b7bebd37d23098ffb11c6cc9060b37c0cd65c0e64ad0df2d0a2
PMID 12544834
ParticipantIDs pubmed_primary_12544834
PublicationCentury 2000
PublicationDate 2003-January-20
PublicationDateYYYYMMDD 2003-01-20
PublicationDate_xml – month: 01
  year: 2003
  text: 2003-January-20
  day: 20
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Neuroreport
PublicationTitleAlternate Neuroreport
PublicationYear 2003
SSID ssj0009018
Score 1.9953268
Snippet Neurodegenerative diseases share symptoms suggested to be related to the serotonergic system. To evaluate the involvement of serotonergic raphe nuclei, we...
SourceID pubmed
SourceType Index Database
StartPage 73
SubjectTerms Aged
alpha-Synuclein
Alzheimer Disease - metabolism
Alzheimer Disease - pathology
Female
Humans
Male
Medulla Oblongata - metabolism
Medulla Oblongata - pathology
Middle Aged
Multiple System Atrophy - metabolism
Multiple System Atrophy - pathology
Nerve Tissue Proteins - analysis
Neurodegenerative Diseases - metabolism
Neurodegenerative Diseases - pathology
Neurons - metabolism
Neurons - pathology
Parkinson Disease - metabolism
Parkinson Disease - pathology
Phosphorylation
Pons - metabolism
Pons - pathology
Protein Processing, Post-Translational
Raphe Nuclei - metabolism
Raphe Nuclei - pathology
Serotonin - biosynthesis
Supranuclear Palsy, Progressive - metabolism
Supranuclear Palsy, Progressive - pathology
Synucleins
tau Proteins - analysis
Tryptophan Hydroxylase - analysis
Title Nucleus-specific alteration of raphe neurons in human neurodegenerative disorders
URI https://www.ncbi.nlm.nih.gov/pubmed/12544834
Volume 14
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8NAFB6qgngR913m4E0ik22aOaq4oyAqeJNkliJoWmzrob_e92YmaW1V1EsIMzAkeV8eb_0eIXtSh0xkmQwAwFGQpEoEhRL4uwsJ7oRRyqYLrm_4-UNy-Zg-NhqD0e6SXnEgB1_2lfxHqrAGcsUu2T9Itj4UFuAe5AtXkDBcfyXjGyQj7ncDbJfEkp99m_uujUDkotb7lrHSlYu7gXx2QemWJZy2lUPKU3B2R01VS9vhUgq1Vm6_566u6AyxM5zLdfWCCfcj3um4pP9dT5sh7E6fuxU0LsoWKrhWbT-336rRX_1BXvocfxWFwBqsIGJj4UTknv-kWZMJBDk16aaXTGhvxwpsEw7NlKOoY-ztta3v7qwRoXZerVRD5FjzAdGfd8d4tautKTIFHgaOTMU4T0XXzGxkuH4rXwNW031-8XhIP-uPHHNRrKlyv0DmvY9BDx1gFklDl0tk9tpXUSyT23Hc0CFuaNtQixvqcUOfS2pxQydwQ2vcrJCH05P74_PAj9YIZAI-aBAbmeos0nFoIpkVzUIXKm4q8EdFZkwRhpJLKRhnRdyUTCqeSqZ5kiumTKRYHq2S6bJd6nVCE6XiHLxmMGt0IiKTCSUk5ywPZS5zE22QNfcxnjqOP-Wp-kyb3-5skbkhyLbJjIEfVu-A9dcrdq2gPgBr_1bf
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nucleus-specific+alteration+of+raphe+neurons+in+human+neurodegenerative+disorders&rft.jtitle=Neuroreport&rft.au=Kovacs%2C+Gabor+G&rft.au=Kl%C3%B6ppel%2C+Stefan&rft.au=Fischer%2C+Ingeborg&rft.au=Dorner%2C+Suzanne&rft.date=2003-01-20&rft.issn=0959-4965&rft.volume=14&rft.issue=1&rft.spage=73&rft_id=info:doi/10.1097%2F00001756-200301200-00014&rft_id=info%3Apmid%2F12544834&rft_id=info%3Apmid%2F12544834&rft.externalDocID=12544834
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0959-4965&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0959-4965&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0959-4965&client=summon